Total submissions: 7
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV002519114 | SCV003683510 | uncertain significance | Inborn genetic diseases | 2024-12-10 | criteria provided, single submitter | clinical testing | The c.950A>T (p.D317V) alteration is located in exon 7 (coding exon 7) of the TRIP11 gene. This alteration results from a A to T substitution at nucleotide position 950, causing the aspartic acid (D) at amino acid position 317 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
| Genome Diagnostics Laboratory, |
RCV002278271 | SCV002567092 | uncertain significance | Connective tissue disorder | 2020-11-20 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV001120672 | SCV002148033 | uncertain significance | Achondrogenesis, type IA | 2022-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 317 of the TRIP11 protein (p.Asp317Val). This variant is present in population databases (rs140416653, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with TRIP11-related conditions. ClinVar contains an entry for this variant (Variation ID: 282580). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Gene |
RCV000264098 | SCV002007495 | uncertain significance | not provided | 2019-10-30 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
| ARUP Laboratories, |
RCV000264098 | SCV001474372 | uncertain significance | not provided | 2019-08-02 | criteria provided, single submitter | clinical testing | The TRIP11 c.950A>T; p.Asp317Val variant (rs140416653), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 282580). This variant is found in the non-Finnish European population with an overall allele frequency of 0.05% (58/123454 alleles) in the Genome Aggregation Database. The aspartate at codon 317 is weakly conserved, and computational analyses (SIFT: damaging, PolyPhen-2: benign) predict conflicting effects of this variant on protein structure/function. However, due to limited information, the clinical significance of the p.Asp317Val variant is uncertain at this time. |
| Illumina Laboratory Services, |
RCV001120672 | SCV001279174 | uncertain significance | Achondrogenesis, type IA | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
| Eurofins Ntd Llc |
RCV000264098 | SCV000334116 | uncertain significance | not provided | 2015-09-04 | criteria provided, single submitter | clinical testing |